Classification of Protein-Binding Sites Using a Spherical Convolutional Neural Network

The analysis and comparison of protein-binding sites aid various applications in the drug discovery process, e.g., hit finding, drug repurposing, and polypharmacology. Classification of binding sites has been a hot topic for the past 30 years, and many different methods have been published. The rapid development of machine learning computational algorithms, coupled with the large volume of publicly available protein–ligand 3D structures, makes it possible to apply deep learning techniques in binding site comparison. Our method uses a cutting-edge spherical convolutional neural network based on the DeepSphere architecture to learn global representations of protein-binding sites. The model was trained on TOUGH-C1 and TOUGH-M1 data and validated with the ProSPECCTs datasets. Our results show that our model can (1) perform well in protein-binding site similarity and classification tasks and (2) learn and separate the physicochemical properties of binding sites. Lastly, we tested the model on a set of kinases, where the results show that it is able to cluster the different kinase subfamilies effectively. This example demonstrates the method’s promise for lead hopping within or outside a protein target, directly based on binding site information

Efficient search and comparison algorithms for 3D protein binding site retrieval and structure alignment from large-scale databases

Finding similar 3D structures is crucial for discovering potential structural, evolutionary, and functional relationships among proteins. As the number of known protein structures has dramatically increased, traditional methods can no longer provide the life science community with the adequate informatics capability needed to conduct large-scale and complex analyses. A suite of high-throughput and accurate protein structure search and comparison methods is essential. To meet the needs of the community, we develop several bioinformatics methods for protein binding site comparison and global structure alignment. First, we developed an efficient protein binding site search that is based on extracting geometric features both locally and globally. The main idea of this work was to capture spatial relationships among landmarks of binding site surfaces and bfuild a vocabulary of visual words to represent the characteristics of the surfaces. A vector model was then used to speed up the search of similar surfaces that share similar visual words with the query interface. Second, we developed an approach for accurate protein binding site comparison. Our algorithm provides an accurate binding site alignment by applying a two-level heuristic process which progressively refines alignment results from coarse surface point level to accurate residue atom level. This setting allowed us to explore different combinations of pairs of corresponding residues, thus improving the alignment quality of the binding site surfaces. Finally, we introduced a parallel algorithm for global protein structure alignment. Specifically, to speed up the time-consuming structure alignment process of protein 3D structures, we designed a parallel protein structure alignment framework to exploit the parallelism of Graphics Processing Units (GPUs). As a general-purpose GPU platform, the framework is capable of parallelizing traditional structure alignment algorithms. Our findings can be applied in various research areas, such as prediction of protein inte

Computational Approaches to Drug Profiling and Drug-Protein Interactions

Despite substantial increases in R&D spending within the pharmaceutical industry, denovo drug design has become a time-consuming endeavour. High attrition rates led to a long period of stagnation in drug approvals. Due to the extreme costs associated with introducing a drug to the market, locating and understanding the reasons for clinical failure is key to future productivity. As part of this PhD, three main contributions were made in this respect. First, the web platform, LigNFam enables users to interactively explore similarity relationships between ‘drug like’ molecules and the proteins they bind. Secondly, two deep-learning-based binding site comparison tools were developed, competing with the state-of-the-art over benchmark datasets. The models have the ability to predict offtarget interactions and potential candidates for target-based drug repurposing. Finally, the open-source ScaffoldGraph software was presented for the analysis of hierarchical scaffold relationships and has already been used in multiple projects, including integration into a virtual screening pipeline to increase the tractability of ultra-large screening experiments. Together, and with existing tools, the contributions made will aid in the understanding of drug-protein relationships, particularly in the fields of off-target prediction and drug repurposing, helping to design better drugs faster

Application of 3D Zernike descriptors to shape-based ligand similarity searching

Background: The identification of promising drug leads from a large database of compounds is an important step in the preliminary stages of drug design. Although shape is known to play a key role in the molecular recognition process, its application to virtual screening poses significant hurdles both in terms of the encoding scheme and speed. Results: In this study, we have examined the efficacy of the alignment independent three-dimensional Zernike descriptor (3DZD) for fast shape based similarity searching. Performance of this approach was compared with several other methods including the statistical moments based ultrafast shape recognition scheme (USR) and SIMCOMP, a graph matching algorithm that compares atom environments. Three benchmark datasets are used to thoroughly test the methods in terms of their ability for molecular classification, retrieval rate, and performance under the situation that simulates actual virtual screening tasks over a large pharmaceutical database. The 3DZD performed better than or comparable to the other methods examined, depending on the datasets and evaluation metrics used. Reasons for the success and the failure of the shape based methods for specific cases are investigated. Based on the results for the three datasets, general conclusions are drawn with regard to their efficiency and applicability

A practical review on the measurement tools for cellular adhesion force

Cell cell and cell matrix adhesions are fundamental in all multicellular organisms. They play a key role in cellular growth, differentiation, pattern formation and migration. Cell-cell adhesion is substantial in the immune response, pathogen host interactions, and tumor development. The success of tissue engineering and stem cell implantations strongly depends on the fine control of live cell adhesion on the surface of natural or biomimetic scaffolds. Therefore, the quantitative and precise measurement of the adhesion strength of living cells is critical, not only in basic research but in modern technologies, too. Several techniques have been developed or are under development to quantify cell adhesion. All of them have their pros and cons, which has to be carefully considered before the experiments and interpretation of the recorded data. Current review provides a guide to choose the appropriate technique to answer a specific biological question or to complete a biomedical test by measuring cell adhesion

Plasmonic artificial virus nano-particles for probing virus-host cell interactions

Targeting of key events in viral infection pathways creates opportunities for virus disease prevention and therapy. Nanoparticles with well-defined surfaces are promising tools for the direct visualization of biological processes and for interrogating virus behavior that is usually determined by the synergistic interplay of multiple factors and involves various transient signaling steps. Smart nanoparticles mimicking enveloped viral particles are thus developed and tested in this work with the aim to de-couple key steps in human immune-deficiency virus HIV-1 trans-infection with an engineerable viral model system. Uni-lamellar liposomes resemble biological lipid bilayer membrane structures with tunable particle size, surface charge, and composition. Pretreatment with ganglioside-GM3-containing liposomes inhibited the binding of HIV-1 by dendritic cells, indicating an essential role for GM3 in virus binding. To equip the liposome based model systems with strong non bleaching optical properties, the membranes were in the next step assembled around noble metal nanoparticle core. Noble metal nanoparticles with a size of 20nm-100nm have extraordinarily large scattering cross-sections and enable prolonged tracking of even individual particles with high temporal and spatial resolutions. The plasmon resonance peak of near-field coupled gold nanoparticles red-shifts within decreasing interparticle separation. The distance dependent optical properties of noble metal nanoparticles were utilized for characterizing clustering levels of breast cancer cell marker protein CD24 and CD44 on immortalized cancer cell lines. These encouraging results supported the choice of gold nanoparticles as core for multi-modal artificial virus nanoparticles. Artificial virus nanoparticles combine the biological versatility of a self-assembled membrane with the unique optical properties of a nanoparticle core. We developed these hybrid materials specifically for the purpose of elucidating key steps of the glycoprotein independent binding and uptake of HIV-1 during trans-infection. Systematic validation experiments revealed that GM3 containing artificial virus nanoparticles (AVNs) recapitulate the initial capture and uptake of viruses by sialoadhesin CD169 presenting cells. The AVNs also reproduced the tendency of the virus to re-distribute into confined cluster spots in cell peripheral areas. Upon contact formation between T cell and DC, the AVNs developed a polarized distribution in which they enriched at the interface between DC and CD4+ T cells. The multimodality of the AVNs was instrumental in determining the detailed location and kinetics of the nanoparticles during the trans-infection process, proving the AVN system to be a unique model system to address key mechanistic questions in the infection pathway of enveloped virus particles

Novel pharmacophore clustering methods for protein binding site comparison

Proteins perform diverse functions within cells. Some of the functions depend on the protein being involved in a protein complex, interacting with other proteins or with other entities (ligands) through specific binding sites on their surface. Comparison of protein binding sites has potential benefits in many research fields, including drug promiscuity studies, polypharmacology and immunology. While multiple methods have been proposed for comparing binding sites, they tend to focus on comparing very similar proteins and have only been developed for small specific datasets or very targeted applications. None of these methods make use of the powerful representation afforded by 3D complex-based pharmacophores. A pharmacophore model provides a description of a binding site, consisting of a group of chemical features arranged in three-dimensional space, that can be used to represent biological activities. Two different pharmacophore comparison and clustering methods based on the Iterative Closest Point (ICP) algorithm are proposed: a 3-dimensional ICP pharmacophore clustering method, and an N-dimensional ICP pharmacophore clustering method. These methods are complemented by a series of data pre-processing methods for input data preparation. The implementation of the methods takes computational representations (pharmacophores) of single molecule or protein complexes as input and produces distance matrices that can be visualised as dendrograms. The methods integrate both alignment-dependent and alignment-independent concepts. Both clustering methods were successfully evaluated using a 31 globulin-binding steroid dataset and a 41 antibody-antigen dataset, and were able to handle a larger dataset of 159 protein homodimers. For the steroid dataset, the resulting classification of ligands shows good correspondence with a classification based on binding affinity. For the antibody-antigen dataset, the classification of antigens reflected both antigen type and binding antibody. The applications to homodimers demonstrated the ability of both clustering methods to handle a larger dataset, and the possibility to visualise N-D pairwise comparisons using structural superposition of binding sites

Bioengineering models of cell signaling

Strategies for rationally manipulating cell behavior in cell-based technologies and molecular therapeutics and understanding effects of environmental agents on physiological systems may be derived from a mechanistic understanding of underlying signaling mechanisms that regulate cell functions. Three crucial attributes of signal transduction necessitate modeling approaches for analyzing these systems: an ever-expanding plethora of signaling molecules and interactions, a highly interconnected biochemical scheme, and concurrent biophysical regulation. Because signal flow is tightly regulated with positive and negative feedbacks and is bidirectional with commands traveling both from outside-in and inside-out, dynamic models that couple biophysical and biochemical elements are required to consider information processing both during transient and steady-state conditions. Unique mathematical frameworks will be needed to obtain an integrated perspective on these complex systems, which operate over wide length and time scales. These may involve a two-level hierarchical approach wherein the overall signaling network is modeled in terms of effective "circuit" or "algorithm" modules, and then each module is correspondingly modeled with more detailed incorporation of its actual underlying biochemical/biophysical molecular interactions